These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26583270)

  • 1. In Response.
    Dasarathy S; Dasarathy J; Khiyami A; Yerian L; McCullough AJ
    J Clin Gastroenterol; 2016 Feb; 50(2):181. PubMed ID: 26583270
    [No Abstract]   [Full Text] [Related]  

  • 2. A Double-blinded Randomized Placebo-controlled Clinical Trial of Omega-3 Fatty Acids for the Treatment of Diabetic Patients With Nonalcoholic Steatohepatitis.
    Torrinhas RS; Waitzberg DL
    J Clin Gastroenterol; 2016 Feb; 50(2):180. PubMed ID: 26448136
    [No Abstract]   [Full Text] [Related]  

  • 3. Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease [corrected].
    Scorletti E; Bhatia L; McCormick KG; Clough GF; Nash K; Calder PC; Byrne CD;
    Contemp Clin Trials; 2014 Mar; 37(2):301-11. PubMed ID: 24556343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression.
    Bhatia L; Scorletti E; Curzen N; Clough GF; Calder PC; Byrne CD
    Atherosclerosis; 2016 Mar; 246():13-20. PubMed ID: 26748347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans.
    Kelley NS
    Metab Syndr Relat Disord; 2016 Nov; 14(9):417-430. PubMed ID: 27710160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis.
    Li YH; Yang LH; Sha KH; Liu TG; Zhang LG; Liu XX
    World J Gastroenterol; 2015 Jun; 21(22):7008-13. PubMed ID: 26078579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice.
    Rodriguez-Echevarria R; Macias-Barragan J; Parra-Vargas M; Davila-Rodriguez JR; Amezcua-Galvez E; Armendariz-Borunda J
    World J Gastroenterol; 2018 Jan; 24(4):461-474. PubMed ID: 29398867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 fatty acids in rheumatoid arthritis.
    Kremer JM
    Del Med J; 1988 Nov; 60(11):679-81. PubMed ID: 2852607
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis.
    De Vizia B; Raia V; Spano C; Pavlidis C; Coruzzo A; Alessio M
    JPEN J Parenter Enteral Nutr; 2003; 27(1):52-7. PubMed ID: 12549599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial.
    Scorletti E; West AL; Bhatia L; Hoile SP; McCormick KG; Burdge GC; Lillycrop KA; Clough GF; Calder PC; Byrne CD
    J Hepatol; 2015 Dec; 63(6):1476-83. PubMed ID: 26272871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospectives on n-3 fatty acids in medical research.
    Dyerberg J; Nordøy A
    J Intern Med Suppl; 1989; 731():237-8. PubMed ID: 2539834
    [No Abstract]   [Full Text] [Related]  

  • 12. Omega-3 fatty acids in prevention of diabetic retinopathy.
    Behl T; Kotwani A
    J Pharm Pharmacol; 2017 Aug; 69(8):946-954. PubMed ID: 28481011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fish oil story--back to Greenland?
    Gajos G
    Cardiology; 2011; 118(4):245-7. PubMed ID: 21757896
    [No Abstract]   [Full Text] [Related]  

  • 14. [EPA and DHA ethyl esters: potential mechanisms of antischemic action].
    Cerbone AM; Piemontino U; Coppola A; Albisinni R; Cimino E; Di Minno G
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):743-4. PubMed ID: 12497815
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of n-3 polyunsaturated fatty acid on coronary heart disease].
    Lu G
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Oct; 18(5):279-81. PubMed ID: 2150806
    [No Abstract]   [Full Text] [Related]  

  • 16. Designer eggs: best way to get your omega-3 fatty acids?
    Consum Rep; 2004 Aug; 69(8):45. PubMed ID: 15243993
    [No Abstract]   [Full Text] [Related]  

  • 17. Triglycerides & omega-3s. Prescription omega-3 fatty acids are now among the hypertriglyceridemia therapies.
    Park NH
    Adv NPs PAs; 2010 Dec; 1(4):36-40. PubMed ID: 21319452
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-chain omega-3 fatty acids: highly concentrated only as ethyl ester].
    MMW Fortschr Med; 2005 Oct; 147(43):61. PubMed ID: 16302427
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mood disorders and omega 3 polyunsaturated fatty acids].
    Ozawa H
    Seishin Shinkeigaku Zasshi; 2009; 111(12):1507-11. PubMed ID: 20344877
    [No Abstract]   [Full Text] [Related]  

  • 20. Omacor effects on serum lipids and clinical outcome.
    Ito MK; Marrs J; Williams C
    Am J Cardiol; 2007 Jan; 99(1):145. PubMed ID: 17196478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.